Optical molecular imaging of lymph nodes using a targeted vascular contrast agent

Journal of Biomedical Optics

Volumn 10, Issue 4, 2005, Pages

  Licha, Kai ^a   Debus, Niels ^a   Emig Vollmer, Sonja ^a   Hofmann, Birte ^a   Hasbach, Michael ^a   Stibenz, Dietger ^a   Sydow, Sabine ^a   Schirner, Michael ^a   Ebert, Bernd ^b   Petzelt, Diethard ^b   Bührer, Christoph ^c,d   Semmler, Wolfhard ^e   Tauber, Rudolf ^c  

^a BAYER PHARMA AG   (Germany)

^b PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Lymph nodes; Near IR fluorescent dye conjugates; Optical imaging; Vascular targeting

Indexed keywords

CONTRAST MEDIUM; FLUORESCENT DYE; L SELECTIN COUNTER RECEPTORS; L-SELECTIN COUNTER-RECEPTORS; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; CYTOLOGY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; FLUORESCENCE MICROSCOPY; INFRARED SPECTROPHOTOMETRY; LYMPH NODE; LYMPH VESSEL; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MOUSE; NUDE MOUSE; TISSUE DISTRIBUTION; VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCENT DYES; LYMPH NODES; LYMPHATIC VESSELS; MEMBRANE PROTEINS; METABOLIC CLEARANCE RATE; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; SPECTROPHOTOMETRY, INFRARED; TISSUE DISTRIBUTION;

CONTRAST MEDIA; DYES; FLUORESCENCE; MONOCLONAL ANTIBODIES; OPTICAL PROPERTIES; TISSUE;

LYMPH NODES; NEAR-IR FLUORESCENT DYE CONJUGATES; VASCULAR TARGETING;

MEDICAL IMAGING;

MUS MUSCULUS;

EID: 32944461813     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.2007967     Document Type: Article

References (37)

1. M. Rudin and R. Weissleder, "Molecular imaging in drug discovery and development," Nat. Rev. Drug Discovery 2, 123-131 (2003). (Pubitemid 37361644)
2. S. Achilefu, "Lighting up tumors with receptor-specific optical molecular probes," Technol. Cancer Res. Treat. 3, 393-409 (2004). (Pubitemid 39096612)
3. K. Licha, "Contrast agents for optical imaging, Top. Curr. Chem. 222, 1-29 (2002).
4. M. De Grand and J. V. Frangioni, "An operational near-infrared fluorescence imaging system prototype for large animal surgery," Technol. Cancer Res. Treat. 2, 553-562 (2003). (Pubitemid 38040617)
5. S. R. Cherry, "In vivo molecular and genomic imaging: new challenges for imaging physics," Phys. Med. Biol. 49, R13-48 (2004). (Pubitemid 38208146)
6. B. Thompson and E. M. Sevick-Muraca, "Near-infrared fluorescence contrast enhanced imaging with intensified charge-coupled device homodyne detection: measurement precision and accuracy," J. Biomed. Opt. 8(1), 111-120 (2003).
7. D. Grosenick, H. Wabnitz, K. T. Moesta, J. Mucke, M. Moller, C. Stroszczynski, J. Stossel, B. Wassermann, P. M. Schlag, and H. Rinneberg, "Concentration and oxygen saturation of haemoglobin of 50 breast tumours determined by time-domain optical mammography," Phys. Med. Biol. 49, 1165-1181 (2004). (Pubitemid 38514782)
8. C. Bremer, V. Ntziachristos, and R. Weissleder, "Optical-based molecular imaging: contrast agents and potential medical applications," Eur. Radiol. 13, 231-243 (2003). (Pubitemid 36798598)
9. J. Zhang, R. E. Campbell, A. Y. Ting, and R. Y. Tsien, "Creating new fluorescent probes for cell biology," Nat. Rev. Mol. Cell Biol. 12, 906-918 (2002). (Pubitemid 35477369)
10. M. D. Kennedy, K. N. Jallad, D. H. Thompson, D. Ben-Amotz, and P. S. Low, "Optical imaging of metastatic tumors using a folate-targeted fluorescent probe," J. Biomed. Opt. 8(4), 636-641 (2003).
11. A. Zaheer, R. E. Lenkinski, A. Mahmood, A. G. Jones, L. C. Cantley, and J. V. Frangioni, "In vivo near-infrared fluorescence imaging of osteoblastic activity," Nat. Biotechnol. 19, 1148-1154 (2001). (Pubitemid 33115701)
12. A. Becker, C. Hessenius, K. Licha, B. Ebert, U. Sukowski, W. Semmler, B. Wiedenmann, and C. Grötzinger, "Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands," Nat. Biotechnol. 19, 327-331 (2001). (Pubitemid 32275340)
13. J. E. Bugaj, S. Achilefu, R. B. Dorshow, and R. Rajagopalan, "Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform," J. Biomed. Opt. 6, 122-133 (2001). (Pubitemid 32546877)
14. B. Ballou, G. W. Fisher, A. S. Waggoner, D. L. Farkas, J. M. Reiland, R. Jaffe, R. B. Mujumdar, S. R. Mujumdar, and T. R. Hakala, "Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies," Cancer Immunol. Immunother 41, 257-263 (1995).
15. D. Neri, B. Carnemolla, A. Nissim, A. Leprini, G. Querze, E. Balza, A. Pini, L. Tarli, C. Halin, P. Neri, L. Zardi, and G. Winter, "Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform," Nat. Biotechnol. 15, 1271-1275 (1997). (Pubitemid 27465138)
16. E. A. Schellenberger, A. Bogdanov, Jr., A. Petrovsky, V. Ntziachristos, R. Weissleder, and L. Josephson, "Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy," Neoplasia 5, 187-192 (2003). (Pubitemid 36754049)
17. R. Weissleder, C. H. Tung, U. Mahmood, and A. Bogdanov, Jr., "In vivo imaging of tumors with protease-activated near-infrared fluorescent probes," Nat. Biotechnol. 17, 375-378 (1999). (Pubitemid 29166041)
18. M. Funovics, R. Weissleder, and C. H. Tung, "Protease sensors for bioimaging," Anal. Bioanal. Chem. 377, 956-963 (2003). (Pubitemid 40877826)
19. J. M. McGreevy, M. J. Cannon, and C. B. Grissom, "Minimally invasive lymphatic mapping using fluorescently labeled vitamin B12," J. Surg. Res. 111, 38-44 (2003). (Pubitemid 36808698)
20. P. Wunderbaldinger, K. Turetschek, and C. Bremer, "Near-infrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromolecular optical probe," Eur. Radiol. 13, 2206-2211 (2003). (Pubitemid 37080758)
21. E. G. Soltesz, S. Kim, R. G. Laurence, A. M. DeGrand, C. P. Parungo, D. M. Dor, L. H. Cohn, M. G. Bawendi, J. V. Frangioni, and T. Mihaljevic, "Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots," Ann. Thorac. Surg. 79, 269-277 (2005). (Pubitemid 40037484)
22. C. P. Parungo, S. Ohnishi, A. M. De Grand, R. G. Laurence, E. G Soltesz, Y L. Colson, P. M. Kang, T. Mihaljevic, L. H. Cohn, and J. V. Frangioni, "In vivo optical imaging of pleural space drainage to lymph nodes of prognostic significance," Ann. Surg. Oncol. 11, 1085-1092 (2004). (Pubitemid 40486655)
23. X. Michalet, F. F. Pinaud, L. A. Bentolila, J. M. Tsay, S. Doose, J. J. Li, G. Sundaresa, A. M. Wu, S. S. Gambhir, and S. Weiss, "Quantum dots for live cells, in vivo imaging, and diagnostics," Science 307, 538-544 (2004).
24. T. M. Tuttle, "Technical advances in sentinel lymph node biopsy for breast cancer," Am. Surg. 70, 407-413 (2004).
25. O. E. Nieweg, S. H. Estourgie, M. C. van Rijk, and B. B. Kroon, "Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients," J. Surg. Oncol. 87, 153-156 (2004). (Pubitemid 39167380)
26. K. T. Moesta, B. Ebert, T. Handke, D. Nolte, C. Nowak, W. E. Haensch, R. K. Pandey, T. J. Dougherty, H. Rinneberg, and P. M. Schlag, "Protoporphyrin IX occurs naturally in colorectal cancers and their metastases," Cancer Res. 61, 991-999 (2001). (Pubitemid 32174416)
27. G. S. Kansas, "Selectins and their ligands: current concepts and controversies," Blood 88, 3259-3287 (1996). (Pubitemid 26365560)
28. A. van Zante and S. D. Rosen, "Sulfated endothelial ligands for L-selectin in lymphocyte homing and inflammation," Biochem. Soc. Trans. 31, 313-317 (2003). (Pubitemid 36520665)
29. A. Varki, "Selectin ligands," Proc. Natl. Acad. Sci. U.S.A. 91, 7390-7397 (1994). (Pubitemid 24238190)
30. T. K. Kishimoto, M. A. Jutila, and E. C. Butcher, "Identification of a human peripheral lymph node homing receptor: a rapidly downregulated adhesion molecule," Proc. Natl. Acad. Sci. U.S.A. 87, 2244-2248 (1990).
31. PR. Streeter, B. T. Rouse, and E. C. Butcher, "Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes," J. Cell Biol. 107, 1853-1862 (1988).
32. C. M'Rini, G. Cheng, G. C. Schweitzer, L. L. Cavanagh, R. T. Palframan, T. R. Mempel, R. A. Warnock, J. B. Lowe, E. J. Quackenbush, and U. H. von Andrian, "A novel endothelial L-selectin ligand activity in lymph node medulla that is regulated by alpha(1,3)-fucosyltransferase-IV," J. Exp. Med. 198, 1301-1312 (2003). (Pubitemid 37392476)
33. P. Hauff, M. Reinhardt, A. Briel, N. Debus, and M. Schirner, "Molecular targeting of lymph nodes with L-selectin ligand-specific US contrast agent: a feasibility study in mice and dogs," Radiology 231, 667-673 (2004). (Pubitemid 38668081)
34. K. Licha, A. Becker, C. Hessenius, M. Bauer, S. Wisniewski, P. Henklein, B. Wiedenmann, and W Semmler, "Synthesis, characterization and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes," Bioconjugate Chem. 12, 44-50 (2001). (Pubitemid 32111452)
35. A. Becker, B. Riefke, B. Ebert, U. Sukowski, H. Rinneberg, W Semmler, and K. Licha, "Macromolecular contrast agents for optical imaging of tumors: comparison of indotricarbocyanine-labeled human serum albumin and transferrin," Photochem. Photobiol. 72, 234-241 (2000).
36. G. S. Bailey, "Labeling of peptides and proteins by radioiodination," Methods Mol. Biol. 32, 441-448 (1994).
37. R. C. Benson and H. A. Kues, "Absorption and fluorescence properties of cyanine dyes," J. Chem. Eng. Data 22, 379-383 (1977).